Search - tctmd.com

Displaying 381 - 400 of 453

Sort: Relevancy | Date

Presentation TVT 2022

You’re All Wrong: A Toolbox Approach Is the Future of Transcatheter Mitral Intervention!

Presenter: Vinod H. Thourani

June 08, 2022

Presentation TVT 2022

When Is Surgery the First Choice?

Presenter: Mathew Williams

June 08, 2022

Presentation TVT 2022

Evoque: Compassionate Use and TRISCEND I Results

Presenter: Charles J. Davidson

June 08, 2022

Presentation TVT 2022

One-Year Outcomes in Patients With Secondary MR Outside the COAPT Criteria: From the MitraClipTM Global EXPAND Study

Presenter: Gilbert Tang

June 08, 2022

Presentation TVT 2022

TTVR Design Requirements: Lessons From Surgery

Presenter: Vinayak Bapat

June 08, 2022

Presentation TVT 2022

Perspective 2: Annular Reduction Will Usually Be Needed, Stand-Alone or Complementing TEER!

Presenter: Brian Whisenant

June 08, 2022

Presentation TVT 2022

Forget Sievers, CT Phenotyping and Calcium Reign Supreme in Bicuspid Disease!

Presenter: Hasan Jilaihawi

June 08, 2022

Presentation TVT 2022

Perspective 1: Targeting the Leaflets Will Be Enough – Future Generation TEER Technologies Will Have It All!

Presenter: D. Scott Lim

June 08, 2022

Presentation TVT 2022

Contemporary Outcomes of TMVR With SAPIEN 3/Ultra for Failed Surgical Repairs With Annuloplasty Rings in the US

Presenter: James McCabe

June 08, 2022

Presentation TVT 2022

Potential Solutions: Alternative TMVr Concepts – Annuloplasty and Chordal Replacement Technologies

Presenter: Scott Lim

June 08, 2022

Presentation TVT 2022

Transcatheter Aortic Valve Replacement With the Self-Expanding ACURATE neo2: Hemodynamic Performance and Clinical Outcomes

Presenter: Andrea Scotti

June 08, 2022

Presentation TVT 2022

My Biggest TMVr Frustration: Achieving Consistent and Predictable Results in the “Real World”

Presenter: Paul Sorajja

June 08, 2022

Presentation TVT 2022

First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials

Presenter: Georg Nickenig

June 08, 2022

Presentation TVT 2022

Innovation in TMVr: Lessons Learned From the Surgeons

Presenter: Thomas Modine

June 08, 2022

Presentation TVT 2022

Heterotopic Tricuspid Valve Replacement: Considerations for Future Clinical Trials

Presenter: Ori Ben-Yehuda

June 08, 2022

Presentation TVT 2022

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Presenter: Michael J. Reardon

June 08, 2022

Presentation TVT 2022

Heterotopic Tricuspid Valve Replacement: Future Developments and Novel Applications

Presenter: Brian O'Neill

June 08, 2022

Presentation TVT 2022

Surgical Explants After TAVI Failures: Prohibitive or an Acquired Taste

Presenter: Tsuyoshi Kaneko

June 08, 2022

Presentation TVT 2022

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

Presenter: Janarthanan Sathananthan

June 08, 2022

Presentation TVT 2022

COUNTERPOINT: EU Preferences… Class 1 = ≥ 75 yo

Presenter: Haim Danenberg

June 08, 2022

Advertisement

You’re All Wrong: A Toolbox Approach Is the Future of Transcatheter Mitral Intervention!

When Is Surgery the First Choice?

Evoque: Compassionate Use and TRISCEND I Results

One-Year Outcomes in Patients With Secondary MR Outside the COAPT Criteria: From the MitraClipTM Global EXPAND Study

TTVR Design Requirements: Lessons From Surgery

Perspective 2: Annular Reduction Will Usually Be Needed, Stand-Alone or Complementing TEER!

Forget Sievers, CT Phenotyping and Calcium Reign Supreme in Bicuspid Disease!

Perspective 1: Targeting the Leaflets Will Be Enough – Future Generation TEER Technologies Will Have It All!

Contemporary Outcomes of TMVR With SAPIEN 3/Ultra for Failed Surgical Repairs With Annuloplasty Rings in the US

Potential Solutions: Alternative TMVr Concepts – Annuloplasty and Chordal Replacement Technologies

Transcatheter Aortic Valve Replacement With the Self-Expanding ACURATE neo2: Hemodynamic Performance and Clinical Outcomes

My Biggest TMVr Frustration: Achieving Consistent and Predictable Results in the “Real World”

First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials

Innovation in TMVr: Lessons Learned From the Surgeons

Heterotopic Tricuspid Valve Replacement: Considerations for Future Clinical Trials

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Heterotopic Tricuspid Valve Replacement: Future Developments and Novel Applications

Surgical Explants After TAVI Failures: Prohibitive or an Acquired Taste

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

COUNTERPOINT: EU Preferences… Class 1 = ≥ 75 yo

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content